TY  - GEN
AU  - González-Martín,A J
AU  - Calvo,E
AU  - Bover,I
AU  - Rubio,M J
AU  - Arcusa,A
AU  - Casado,A
AU  - Ojeda,B
AU  - Balañá,C
AU  - Martínez,E
AU  - Herrero,A
AU  - Pardo,B
AU  - Adrover,E
AU  - Rifá,J
AU  - Godes,M J
AU  - Moyano,A
AU  - Cervantes,A
TI  - Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study
SN  - 0923-7534
PY  - 2005///0901
KW  - Adult
KW  - Aged
KW  - Carboplatin
KW  - administration & dosage
KW  - Chemotherapy, Adjuvant
KW  - Confidence Intervals
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Neoplasm Staging
KW  - Ovarian Neoplasms
KW  - mortality
KW  - Ovariectomy
KW  - methods
KW  - Paclitaxel
KW  - Palliative Care
KW  - Probability
KW  - Prognosis
KW  - Quality of Life
KW  - Risk Assessment
KW  - Spain
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdi147
ER  -